High-performance diagnostic platforms engineered for clinical excellence and laboratory efficiency.
Navigating the evolution of laboratory medicine under the "Digital Uzbekistan 2030" initiative.
Uzbekistan is currently undergoing a radical transformation in its healthcare and agricultural sectors. As part of the government's drive to modernize medical facilities in Tashkent, Samarkand, and Bukhara, there is an unprecedented demand for Real-Time PCR (qPCR) systems. These systems are no longer luxury items but essential tools for infectious disease monitoring, oncology, and prenatal screening.
Our role as a leading manufacturer is to bridge the technological gap by providing high-throughput, reliable nucleic acid analysis platforms that meet the rigorous standards of the Ministry of Health of the Republic of Uzbekistan. By integrating AI-driven analysis and cloud-based data management, our systems empower local clinicians to make faster, evidence-based decisions.
Understanding the specific ecological and industrial needs of Uzbekistan allows us to tailor our Real-Time PCR solutions for maximum "Information Gain":
As we look toward 2025-2030, our R&D focus is on Multiplexing and Miniaturization. Our portable PCR systems (like the Ma-1630) represent the first wave of decentralized testing, allowing diagnostic capabilities to reach remote regions of the Fergana Valley. Future iterations will include integrated CRISPR-based detection and enhanced 6-channel fluorescence for ultra-complex diagnostic panels.
Leveraging China's premier biotechnology hub to serve Uzbekistan with speed and reliability.
Operating from Shenzhen, China’s "Silicon Valley," Shenzhen BioX Medical Co., Ltd. benefits from a world-class electronics and biomedical ecosystem. This allows us to offer:
Direct factory-to-hospital supply chains eliminate middleman markups, ensuring Uzbekistan laboratories receive premium technology at sustainable prices.
Strategic proximity to the "Belt and Road" logistics corridors ensures shorter lead times for equipment and reagents compared to Western counterparts.
Customized software localized in Uzbek or Russian, and hardware branding for large-scale national laboratory tenders.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.
Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.
Expert answers regarding PCR implementation in Uzbekistan.
Yes, all BioX Medical systems are manufactured under ISO 13485 standards and we provide all necessary technical documentation and CE certifications required for registration with the Ministry of Health of Uzbekistan.
We provide comprehensive online technical support 24/7. Additionally, we partner with local distributors in Tashkent to offer on-site installation, maintenance, and clinical application training.
Standard orders typically ship within 7-10 working days from our Shenzhen facility. Transit time via air freight to Tashkent International Airport is approximately 5-7 days.
Absolutely. Our high-end models, such as the Gentier series, support up to 6 fluorescence channels, enabling the detection of multiple targets in a single reaction, which is ideal for comprehensive respiratory or STI panels.
Scalable solutions for every laboratory size and budget.
BioX Medical
